Agonist-inverse agonist characterization at CB1 and CB2 cannabinoid receptors of L759633, L759656 and AM630

British Journal of Pharmacology

Volumn 126, Issue 3, 1999, Pages 665-672

  Ross, Ruth A ^a   Brockie, Heather C ^a   Stevenson, Lesley A ^a   Murphy, Vicki L ^a   Templeton, Fiona ^a   Makriyannis, Alexandros ^b   Pertwee, Roger G ^a  

^a UNIVERSITY OF ABERDEEN   (United Kingdom)

^b UNIVERSITY OF CONNECTICUT   (United States)

Author keywords

35S GTP S; AM630; Cannabinoid CB1 and CB2 receptors; CB1 selective agonist; CB2 selective inverse agonist; CB2 selective ligands; Cyclic AMP; L759633; L759656

Indexed keywords

4 (1,1 DIMETHYLHEPTYL) 1',2',3',4',5',6' HEXAHYDRO 2,3' DIHYDROXY 6' (3 HYDROXYPROPYL)BIPHENYL; 6 IODO 3 (4 METHOXYBENZOYL) 2 METHYL 1 (2 MORPHOLINOETHYL)INDOLE; CANNABINOID RECEPTOR; CANNABINOID RECEPTOR AGONIST; CYCLIC AMP; L 759633; L 759656; UNCLASSIFIED DRUG;

ANIMAL CELL; ARTICLE; BINDING AFFINITY; CHO CELL; NONHUMAN; PRIORITY JOURNAL;

ANIMALS; BINDING, COMPETITIVE; BORNANES; CANNABINOIDS; CHO CELLS; CHROMANS; CRICETINAE; CYCLIC AMP; CYCLOHEXANOLS; FORSKOLIN; GUANOSINE 5'-O-(3-THIOTRIPHOSPHATE); HUMANS; INDOLES; MORPHOLINES; NAPHTHALENES; PYRAZOLES; RADIOLIGAND ASSAY; RECEPTORS, CANNABINOID; RECEPTORS, DRUG; TRITIUM;

EID: 0032982010     PISSN: 00071188     EISSN: None     Source Type: Journal    
DOI: 10.1038/sj.bjp.0702351     Document Type: Article

References (22)

1. BOUABOULA, M., PERRACHON, S., MILLIGAN, L., CANAT, X., RINALDI-CARMONA, M., PORTIER, M., BARTH, F., CALANDRA, B., PECCEU, F., LUPKER, J., MAFFRAND, J.-P., LE FUR, G. & CASSELLAS, P. (1997). A selective inverse agonist for central cannabinoid receptor inhibits mitogen-activated protein kinase activation stimulated by insulin or insulin-like growth factor I. Evidence for a new model of receptor/ligand interactions. J. Biol. Chem., 272, 22330-22339.
2. BREIVOGEL, C.S., SIM, L.J. & CHILDERS, S.R. (1997). Regional differences in cannabinoid receptor G-protein coupling in rat brain. J. Pharmacol. Exp. Ther., 282, 1632-1642.
3. 50) of an enzymatic reaction. Biochem. Pharmacol., 22, 3099-3108.
4. COLQUHOUN, D. (1971). Lectures on Biostatistics. Oxford University Press., Oxford.
5. COMPTON, D.R., RICE, K.C., DE COSTA, B.R., RAZDAN, R.K., MELVIN, L.S., JOHNSON, M.R. & MARTIN, B.R. (1993). Cannabinoid structure-activity relationships: correlation of receptor binding and in vivo activities. J. Pharmacol. Exp. Ther., 265, 218-226.
6. 2 receptors. Mol. Pharmacol., 48, 443-450.
7. GAREAU, Y., DUFRESNE, C., GALLANT, M., ROCHETTE, C., SAWYER, N., SLIPETZ, D.M., TREMBLAY, N., WEECH, P.K., METTERS, K.M. & LABELLE, M. (1996). Structure activity relationships of tetrahydrocannabinol analogues on human cannabinoid receptors. Bioorg. Med. Chem. Letts., 6, 189-194.
8. s linkage to the CB1 receptor. J. Neuroscience, 17, 5327-5333.
9. 2 receptors for the identification of novel agonists. Symposium on the Cannabinoids, Burlington, Vermont, International Cannabinoid Research Society, 102.
10. GRIFFIN, G., FERNANDO, S.R., ROSS, R.A., MCKAY, N.G., ASHFORD, M.L.J., SHIRE, D., HUFFMAN, J.W., YU, S., LAINTON, J.A.H. & PERTWEE, R.G. (1997). Evidence for the presence of CB2-like cannabinoid receptors on peripheral nerve terminals. Eur. J. Pharmacol., 339, 53-61.
11. HOSOHATA, K., QUOCK, R.M., HOSOHATA, Y., BURKEY, T.H., MAKRIYANNIS, A., CONSROE, P., ROESKE, W.R. & YAMAMURA, H.I. (1997a). AM630 is a competitive cannabinoid receptor antagonist in the guinea pig brain. Life Sci., 61, PL115-118.
12. 35S]GTPγS binding in the mouse brain. Eur. J. Pharmacol., 321, R1-R3.
13. KENAKIN, T. (1995). Agonist-receptor efficacy 1: mechanisms of efficacy and receptor promiscuity. Trends Pharmacol. Sci., 16, 188-192.
14. LANDSMAN, R.S., MAKRIYANNIS, A., DENG, H., CONSROE, P., ROESKE, W.R. & YAMAMURA, H.I. (1998). AM630 is an inverse agonist at the human cannabinoid CB1 receptor. Life Sci., 62, PL109-PL113.
15. 2 receptors. Br. J. Pharmacol., 124, 619-622.
16. MUNRO, S., THOMAS, K.L. & ABU-SHAAR, M. (1993). Molecular characterization of a peripheral receptor for cannabinoids. Nature, 365, 61-65.
17. 2 receptors. Pharmacol. Ther., 74, 129-180.
18. PERTWEE, R.G. (1998). Cannabinoid receptors and their ligands in brain and other tissues. In Marihuana and Medicine. ed. Nahas, G.G., Sutin, K.M. & Agurell, S., Totowa: Humana Press. (in press).
19. 1 receptors in guinea-pig small intestine. Br. J. Pharmacol., 118, 2199-2205.
20. PERTWEE, R., GRIFFIN, G., FERNANDO, S., LI, X., HILL, A. & MAKRIYANNIS, A. (1995). AM630, a competitive cannabinoid receptor antagonist. Life Sci., 56, 1949-1955.
21. RINALDI-CARMONA, M., BARTH, F., MILLAN, J., DEROCQ, J.-M., CASSELLAS, P., CONGY, C., OUSTRIC, D., SARRAN, M., BOUABOULA, M., CALANDRA, B., PORTIER, M., SHIRE, D., BRELIERE, J.-C. & LE FUR, G. (1998). SR 144528, the first potent and selective antagonist of the CB2 cannabinoid receptor. J. Pharmacol. Exp. Ther., 284, 644-650.
22. SHOWALTER, V.M., COMPTON, D.R., MARTIN, B.R. & ABOOD, M.E. (1996). Evaluation of binding in a transfected cell line expressing a peripheral cannabinoid receptor (CB2): identification of cannabinoid receptor subtype selective ligands. J. Pharmacol. Exp. Ther., 278, 989-999.